Skip to main content

Advertisement

SpringerLink
Log in

Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Foxp3 is a specific marker for regulatory T cells (Tregs), and interleukin (IL)-17 is the signature cytokine of T-helper (Th) 17 cells. Recent studies suggested that Foxp3+ Tregs and IL-17+ Th17 cells may be involved in pathogenesis of lichen planus (LP). The objectives of this study were to examine the immunoexpression of Foxp3 and IL-17 in archival paraffin-embedded biopsy specimens from 80 cases of LP (oral LP, n = 42; cutaneous LP, n = 38) and compare against normal control tissues (oral mucosa, n = 10; skin, n = 10). The results showed that the mean number of Foxp3 and IL-17 expression in LP was significantly higher compared to controls, respectively (both P < 0.001). A positive correlation between Foxp3 and IL-17 expression (r = 0.273; P = 0.014) was observed. Moreover, the mean number of Foxp3 expression in oral LP was significantly higher than cutaneous LP (P < 0.001). Collectively, our findings demonstrated the increased expression of Foxp3 and IL-17 in LP lesions including oral and cutaneous variants. Foxp3 expressing in oral LP was higher than cutaneous LP, which may be associated with the difference in clinical behaviour of the two variants of the disease. Further studies are required to investigate the immunopathologic mechanisms and therapeutic target of Foxp3+ Tregs and IL-17+ Th17 cells in LP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abdel-Latif AM, Abuel-Ela HA, El-Shourbagy SH (2009) Increased caspase-3 and altered expression of apoptosis- associated proteins, Bcl-2 and Bax in lichen planus. Clin Exp Dermatol 34:390–395

    Article  CAS  PubMed  Google Scholar 

  2. Baccaglini L, Thongprasom K, Carrozzo M, Bigby M (2013) Urban legends series: lichen planus. Oral Dis 19:128–143

    CAS  PubMed  Google Scholar 

  3. Boyd AS, Neldner KH (1991) Lichen planus. J Am Acad Dermatol 25:593–619

    Article  CAS  PubMed  Google Scholar 

  4. Farhi D, Dupin N (2010) Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 28:100–108

    Article  PubMed  Google Scholar 

  5. Hasséus B, Jontell M, Bergenholtz G, Dahlgren UI (2004) Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin. Clin Exp Immunol 136:483–489

    Article  PubMed Central  PubMed  Google Scholar 

  6. Hu Y, Shen F, Crellin NK, Ouyang W (2011) The IL-17 pathway as a major therapeutic target in autoimmune diseases. Ann N Y Acad Sci 1217:60–76

    Article  CAS  PubMed  Google Scholar 

  7. Irvine C, Irvine F, Champion RH (1991) Long-term follow-up of lichen planus. Acta Derm Venereol 71:242–244

    CAS  PubMed  Google Scholar 

  8. Lage D, Pimentel VN, Soares TC, Souza EM, Metze K, Cintra ML (2011) Perforin and granzyme B expression in oral and cutaneous lichen planus: a comparative study. J Cutan Pathol 38:973–978

    Article  PubMed  Google Scholar 

  9. Lan Q, Fan H, Quesniaux V, Ryffel B, Liu Z, Zheng SG (2012) Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol 4:22–28

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Mai J, Wang H, Yang XF (2010) Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci 15:986–1006

    Article  CAS  Google Scholar 

  11. Miyara M, Sakaguchi S (2011) Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol 89:346–351

    Article  CAS  PubMed  Google Scholar 

  12. Miossec P, Kolls JK (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11:763–776

    Article  CAS  PubMed  Google Scholar 

  13. Pereira JS, Monteiro BV, Nonaka CF, Silveiraé J, Miguel MC (2012) FoxP3(+) T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions. Int J Exp Pathol 93:287–294

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Piccinni MP, Lombardelli L, Logiodice F et al (2013) Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Dis. doi:10.1111/odi.12094

    PubMed  Google Scholar 

  15. Ragaz A, Ackerman AB (1981) Evolution, maturation, and regression of lesions of lichen planus: new observations and correlations of clinical and histologic findings. Am J Dermatopathol 3:5–25

    Article  CAS  PubMed  Google Scholar 

  16. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus: a review. J Oral Pathol Med 39:729–734

    Article  CAS  PubMed  Google Scholar 

  17. Santoro A, Majorana A, Bardellini E et al (2004) Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus. Am J Clin Pathol 121:758–764

    Article  PubMed  Google Scholar 

  18. Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F (2003) NF-kappaB expression in oral and cutaneous lichen planus. J Pathol 201:466–472

    Article  CAS  PubMed  Google Scholar 

  19. Scully C, Carrozzo M (2008) Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 46:15–21

    Article  PubMed  Google Scholar 

  20. Shaker O, Hassan AS (2012) Possible role of interleukin-17 in the pathogenesis of lichen planus. Br J Dermatol 166:1367–1368

    Article  CAS  PubMed  Google Scholar 

  21. Tao XA, Li CY, Xia J et al (2009) Differential gene expression profiles of whole lesions from patients with oral lichen planus. J Oral Pathol Med 38:427–433

    Article  CAS  PubMed  Google Scholar 

  22. Tao XA, Xia J, Chen XB et al (2010) FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis 16:76–82

    Article  PubMed  Google Scholar 

  23. van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32:507–512

    Article  PubMed  Google Scholar 

  24. Vered M, Fürth E, Shalev Y, Dayan D (2013) Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters. Clin Oral Investig 17:1365–1373

    Article  PubMed  Google Scholar 

  25. Wang H, Luo Z, Lei L et al (2013) Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum. Inflammation 36:696–704

    Article  CAS  PubMed  Google Scholar 

  26. Xie S, Ding L, Xiong Z, Zhu S (2012) Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus. J Huazhong Univ Sci Technol Med Sci 32:451–457

    Article  CAS  PubMed  Google Scholar 

  27. Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457–462

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by National Natural Science Foundation of China (81200786, 81302358), Science and Technology Commission of Shanghai (13401905700), and Shanghai Natural Science Foundation (12ZR1417000).

Author information

Authors and Affiliations

  1. Department of Dermatology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, 200011, China

    Zhengyu Shen

  2. Department of Stomatology, XiangYa Hospital, Central South University, Changsha, Hunan, China

    Liwei Ma

  3. Shanghai Key Laboratory of Stomatology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, 200011, China

    Zengtong Zhou, Xuemin Shen & Wei Liu

  4. Department of Oral and Maxillofacial Surgery, XiangYa Hospital, Central South University, Changsha, Hunan, China

    Xing Gao

Authors
  1. Zhengyu Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xing Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liwei Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zengtong Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xuemin Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xuemin Shen or Wei Liu.

Additional information

Z. Shen and X. Gao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shen, Z., Gao, X., Ma, L. et al. Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants. Arch Dermatol Res 306, 441–446 (2014). https://doi.org/10.1007/s00403-013-1429-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-013-1429-3

Keywords

Search

Navigation